Yu Yang Soon

3.0k total citations · 1 hit paper
86 papers, 2.0k citations indexed

About

Yu Yang Soon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yu Yang Soon has authored 86 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 36 papers in Oncology and 23 papers in Surgery. Recurrent topics in Yu Yang Soon's work include Lung Cancer Treatments and Mutations (22 papers), Head and Neck Cancer Studies (12 papers) and Brain Metastases and Treatment (11 papers). Yu Yang Soon is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Head and Neck Cancer Studies (12 papers) and Brain Metastases and Treatment (11 papers). Yu Yang Soon collaborates with scholars based in Singapore, Australia and China. Yu Yang Soon's co-authors include Ivan Weng Keong Tham, Wee Yao Koh, Martin R. Stockler, Balamurugan Vellayappan, Jeremy Tey, Cheng Nang Leong, Raghav Sundar, Benjamin Kye Jyn Tan, Chong Boon Teo and Yiong Huak Chan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Yu Yang Soon

83 papers receiving 2.0k citations

Hit Papers

Efficacy of covid-19 vaccines in immunocompromised patien... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Yang Soon Singapore 22 882 795 417 393 223 86 2.0k
Ji Yun Lee South Korea 24 662 0.8× 708 0.9× 281 0.7× 281 0.7× 104 0.5× 105 1.9k
Junshik Hong South Korea 25 498 0.6× 685 0.9× 182 0.4× 67 0.2× 216 1.0× 179 2.0k
Andrew W. Maksymiuk Canada 25 665 0.8× 1.3k 1.6× 160 0.4× 308 0.8× 72 0.3× 56 2.3k
William G. Hocking United States 18 1.4k 1.6× 613 0.8× 248 0.6× 47 0.1× 231 1.0× 48 2.3k
Guglielmo Nasti Italy 32 427 0.5× 1.7k 2.2× 496 1.2× 376 1.0× 135 0.6× 154 3.1k
Lisa Derosa France 25 1.0k 1.1× 1.7k 2.2× 321 0.8× 345 0.9× 85 0.4× 111 3.2k
Ronald Sobecks United States 29 237 0.3× 1.2k 1.5× 115 0.3× 125 0.3× 624 2.8× 255 3.5k
Reury-Perng Perng Taiwan 26 1.6k 1.8× 1.1k 1.3× 328 0.8× 214 0.5× 51 0.2× 78 2.3k
Sophie Papa United Kingdom 23 287 0.3× 952 1.2× 120 0.3× 271 0.7× 64 0.3× 57 1.8k
Rejin Kebudi Türkiye 21 470 0.5× 573 0.7× 293 0.7× 63 0.2× 217 1.0× 148 1.9k

Countries citing papers authored by Yu Yang Soon

Since Specialization
Citations

This map shows the geographic impact of Yu Yang Soon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Yang Soon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Yang Soon more than expected).

Fields of papers citing papers by Yu Yang Soon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Yang Soon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Yang Soon. The network helps show where Yu Yang Soon may publish in the future.

Co-authorship network of co-authors of Yu Yang Soon

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Yang Soon. A scholar is included among the top collaborators of Yu Yang Soon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Yang Soon. Yu Yang Soon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Soon, Yu Yang, Ainsley Ryan Yan Bin Lee, Shi Yin Wong, et al.. (2024). Lenalidomide, ixazomib, or daratumumab maintenance therapy in multiple myeloma. PubMed. 1(4). 100042–100042. 1 indexed citations
3.
Zheng, Huili, Timothy Cheo, Shing Fung Lee, et al.. (2024). Stroke Risk in Survivors of Head and Neck Cancer. JAMA Network Open. 7(2). e2354947–e2354947. 8 indexed citations
4.
Huang, Yiqing, Joseph J. Zhao, Yu Yang Soon, et al.. (2023). Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer. Cancers. 15(10). 2733–2733. 12 indexed citations
5.
Meng, Tiebao, W.Y. Koh, Michelle Tseng, et al.. (2023). Adjuvant Breast Radiation Therapy for Early-Stage Breast Cancer or Ductal Carcinoma In-Situ in the Breast: A Systematic Review and Network Meta-Analysis of Randomized Trials. International Journal of Radiation Oncology*Biology*Physics. 117(2). e214–e214. 1 indexed citations
6.
Lee, Ainsley Ryan Yan Bin, Lauren Shapiro, Astha Thakkar, et al.. (2022). Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysis. European Journal of Cancer. 172. 65–75. 26 indexed citations
9.
Tey, Jeremy, Francis Ho, Wee Yao Koh, et al.. (2021). Palliative radiotherapy for bladder cancer: a systematic review and meta-analysis. Acta Oncologica. 60(5). 635–644. 11 indexed citations
10.
Soon, Yu Yang, et al.. (2021). Prophylactic irradiation of tracts in patients with malignant pleural mesothelioma: A systematic review and meta-analysis of randomized trials. Critical Reviews in Oncology/Hematology. 160. 103278–103278. 5 indexed citations
11.
Zheng, Huili, et al.. (2021). Risk of Stroke in Nasopharyngeal Cancer Survivors. Neurology. 98(2). e115–e124. 4 indexed citations
12.
Zhao, Joseph J., Dominic Wei Ting Yap, Yiong Huak Chan, et al.. (2021). Low Programmed Death-Ligand 1–Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma. Journal of Clinical Oncology. 40(4). 392–402. 112 indexed citations
15.
Lim, Keith H.C., David Chia, Yew Lam Chong, et al.. (2019). Clinical outcomes of external beam radiotherapy in patients with localized prostate cancer: Does dose escalation matter?. Asia-Pacific Journal of Clinical Oncology. 15(6). 323–330. 2 indexed citations
16.
Ho, Francis, Jeremy Tey, David Chia, et al.. (2018). Implementation of temporal lobe contouring protocol in head and neck cancer radiotherapy planning. Medicine. 97(38). e12381–e12381. 7 indexed citations
17.
Tseng, Michelle, et al.. (2018). Quality of head and neck radiotherapy reporting in randomized controlled trials. Head & Neck. 40(8). 1854–1860. 2 indexed citations
18.
Soon, Yu Yang, et al.. (2018). Quality of radiotherapy reporting in randomized controlled trials of prostate cancer. Radiation Oncology. 13(1). 108–108. 6 indexed citations
19.
Vellayappan, Balamurugan, Yu Yang Soon, Arul Earnest, et al.. (2014). Accuracy of 18 F-flurodeoxyglucosepositron emission tomography/computed tomography in the staging of newly diagnosed nasopharyngeal carcinoma: a systematic review and meta-analysis. Radiology and Oncology. 48(4). 331–338. 22 indexed citations
20.
Kiely, Belinda E., Yu Yang Soon, Martin H.N. Tattersall, & Martin R. Stockler. (2010). How Long Have I Got? Estimating Typical, Best-Case, and Worst-Case Scenarios for Patients Starting First-Line Chemotherapy for Metastatic Breast Cancer: A Systematic Review of Recent Randomized Trials. Journal of Clinical Oncology. 29(4). 456–463. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026